Literature DB >> 2879480

Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.

J Vamecq, J P Draye, F Van Hoof, J P Misson, P Evrard, G Verellen, H J Eyssen, J Van Eldere, R B Schutgens, R J Wanders.   

Abstract

Biologic, morphologic, and biochemical investigations performed in 2 patients demonstrate multiple peroxisomal deficiencies in the cerebrohepatorenal syndrome of Zellweger (CHRS) and neonatal adrenoleukodystrophy (NALD). Very long chain fatty acids, abnormal bile acids, including bile acid precursors (di- and trihydroxycoprostanoic acids), and C29-dicarboxylic acid accumulated in plasma in both patients. Generalized hyperaminoaciduria was also present. Peroxisomes could not be detected in CHRS liver and kidney; however, in the NALD patient, small and sparse cytoplasmic bodies resembling altered peroxisomes were found in hepatocytes. Hepatocellular and Kupffer cell lysosomes were engorged with ferritin and contained clefts and trilaminar structures believed to represent very long chain fatty acids. Enzymatic deficiencies reflected the peroxisomal defects. Hepatic glycolate oxidase and palmitoyl-CoA oxidase activities were deficient. No particle-bound catalase was found in cultured fibroblasts, and ether glycerolipid (plasmalogen) biosynthesis was markedly reduced. Administration of phenobarbital and clofibrate, an agent that induces peroxisomal proliferation and enzymatic activities, to the NALD patient did not bring about any changes in plasma metabolites, liver peroxisome population, or oxidizing activities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2879480      PMCID: PMC1888479     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

Review 1.  Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects.

Authors:  R I Kelley
Journal:  Am J Med Genet       Date:  1983-12

2.  Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA.

Authors:  J Vamecq; F Van Hoof
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

3.  The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis.

Authors:  A E Moser; I Singh; F R Brown; G I Solish; R I Kelley; P J Benke; H W Moser
Journal:  N Engl J Med       Date:  1984-05-03       Impact factor: 91.245

4.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome.

Authors:  R B Schutgens; G J Romeyn; R J Wanders; H van den Bosch; G Schrakamp; H S Heymans
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

5.  Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome.

Authors:  H S Heymans; H vd Bosch; R B Schutgens; W H Tegelaers; J U Walther; J Müller-Höcker; P Borst
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

6.  Mitochondrial myopathy with loosely coupled oxidative phosphorylation in a case of Zellweger syndrome. A cytochemical-ultrastructural study.

Authors:  J Müller-Höcker; J U Walther; K Bise; D Pongratz; G Hübner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

7.  Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome.

Authors:  R J Wanders; M Kos; B Roest; A J Meijer; G Schrakamp; H S Heymans; W H Tegelaers; H van den Bosch; R B Schutgens; J M Tager
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

8.  Serum very long chain fatty acid pattern in Zellweger syndrome.

Authors:  J A Bakkeren; L A Monnens; J M Trijbels; J M Maas
Journal:  Clin Chim Acta       Date:  1984-04-27       Impact factor: 3.786

9.  Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.

Authors:  I Singh; A E Moser; S Goldfischer; H W Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.

Authors:  N S Datta; G N Wilson; A K Hajra
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

View more
  12 in total

1.  Liver and chorion cytochemistry.

Authors:  F Roels; B De Prest; G De Pestel
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 2.  Inherited peroxisomal disorders involving the nervous system.

Authors:  J B Stephenson
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

3.  Polarizing inclusions in some organs of children with congenital peroxisomal diseases (Zellweger's, Refsum's, chondrodysplasia punctata (rhizomelic form), X-linked adrenoleukodystrophy).

Authors:  I Kerckaert; K P Dingemans; H S Heymans; J Vamecq; F Roels
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders.

Authors:  J L Hughes; A Poulos; E Robertson; C W Chow; L J Sheffield; J Christodoulou; R F Carter
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 5.  Practical guide for morphometry of human peroxisomes on electron micrographs.

Authors:  I Kerckaert; D De Craemer; G Van Limbergen
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 6.  On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

7.  Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders.

Authors:  J L Hughes; D I Crane; E Robertson; A Poulos
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Liver pathology and immunocytochemistry in congenital peroxisomal diseases: a review.

Authors:  F Roels; M Espeel; D De Craemer
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

9.  Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata.

Authors:  J L Hughes; A Poulos; D I Crane; C W Chow; L J Sheffield; D Sillence
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

10.  Hepatic peroxisomes in adrenoleukodystrophy and related syndromes: cytochemical and morphometric data.

Authors:  F Roels; M Pauwels; B T Poll-Thé; J Scotto; H Ogier; P Aubourg; J M Saudubray
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.